Empire Genomics Empire Genomics, Kromatid to Develop Tools for Detecting Cancer Genomic Structural Variations The companies will combine Empire's NGS services and FISH probe portfolio with Kromatid's Pinpoint probes and directional genomic hybridization technology. Empire Genomics Names HemaTone as China Distributor for Cancer Dx Products Empire said it expects to generate $5 million or more in revenues from the Chinese market over the five-year term of the agreement with HemaTone. Empire Genomics Nabs $1.8M Investment The Buffalo, NY-based firm will use the proceeds to grow its marketing, automation, and operations, and to launch additional molecular diagnostic products. New York State Grants Clinical Lab Permit to Empire Genomics The permit will allow the company to offer DNA sequencing and molecular diagnostics for testing of cancer patients. Empire Genomics Lands CE Mark for Several Products The firm's cytogenetic media, immunohistochemistry products, and fish probes have been certified for marketing in Europe. Jan 5, 2015 Empire Genomics Acquires ID Labs Aug 20, 2014 Empire Genomics Partners with Quadpharma to Manufacture ASRs Jul 2, 2014 Empire Genomics Lands $1M Financing Nov 12, 2013 Empire Genomics Clinical Lab Gets CLIA Certification, New York Approval Jun 19, 2013 Life Tech Adds to Clinical NGS Partnerships With University of Buffalo, Empire Genomics Deal Premium Jun 5, 2013 New Next-gen Sequencing Facilities in New York May 29, 2013 With Grant Funding, Empire Advancing Potential Companion Test for Proteasome Inhibitors Premium May 28, 2013 NCI Awards Empire Genomics SBIR Grant to Develop Companion Dx for Multiple Myeloma May 22, 2013 With Exclusive License to Marker, Empire to Launch Neuroendocrine Prostate Cancer Dx This Year Premium May 22, 2013 Empire Genomics Licenses Biomarker from Cornell to Develop Prostate Cancer Dx Nov 29, 2012 Empire Genomics Licenses Biomarker from Emory University for Multiple Myeloma CDx Nov 6, 2012 People in the News: Theresa Brown Premium Nov 2, 2012 In Brief This Week: Becton Dickinson, Corning; Empire Genomics; Emergent Technologies; Octa Phillip Bioscience Managers Jul 27, 2012 People in the News: Michael Becich Premium Apr 24, 2012 Empire Genomics Names Funakoshi its Japan Distributor Nov 9, 2011 Empire Genomics, Icon Team on Personalized Medicine Services Mar 24, 2009 High-Res Arrays Improve Cytogenetics Services as Field Shoots for 'Perfect Platform' Premium Breaking News People in the News at Probius, Flagship Biosciences, Discovery Life Sciences, More New Products Posted to GenomeWeb: BillionToOne, Becton Dickinson, Enzo Biochem, More Stroke Risk Contributors, Treatment Targets Uncovered in Cross-Ancestry GWAS In Brief This Week: Yourgene Health, Bionano Laboratories, Caris Life Sciences, More Enzymatic RNA Synthesis Firm EnPlusOne Biosciences Launches With $12M in Seed Funding The Scan Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says. Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds. Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry. UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.